IDEXX Operating Income from 2010 to 2025

IDXX Stock

USD 417.66 5.94 1.40%

IDEXX Laboratories Operating Income yearly trend continues to be fairly stable with very little volatility. Operating Income is likely to outpace its year average in 2025. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit IDEXX Laboratories generates from its operations. View All Fundamentals

Operating Income

First Reported

1991-03-31

Previous Quarter

303.9 M

Current Value

261.7 M

Quarterly Volatility

80.4 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check IDEXX Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IDEXX Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 136.4 M, Interest Expense of 32.8 M or Total Revenue of 4.1 B, as well as many indicators such as Price To Sales Ratio of 9.17, Dividend Yield of 0.0 or PTB Ratio of 22.4. IDEXX financial statements analysis is a perfect complement when working with IDEXX Laboratories Valuation or Volatility modules.

Check out the analysis of IDEXX Laboratories Correlation against competitors.

For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.

Latest IDEXX Laboratories' Operating Income Growth Pattern

Below is the plot of the Operating Income of IDEXX Laboratories over the last few years. Operating Income is the amount of profit realized from IDEXX Laboratories operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of IDEXX Laboratories is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. IDEXX Laboratories' Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IDEXX Laboratories' overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

IDEXX Operating Income Regression Statistics

	Arithmetic Mean	566,956,303
	Geometric Mean	367,888,644
	Coefficient Of Variation	65.84
	Mean Deviation	316,724,754
	Median	491,335,000
	Standard Deviation	373,288,224
	Sample Variance	139344.1T
	Range	1.2B
	R-Value	0.97
	Mean Square Error	9675.8T
	R-Squared	0.94
	Slope	75,822,948
	Total Sum of Squares	2090161.5T

IDEXX Operating Income History

	2025	1.2 B
	2024	1.1 B
	2023	1.1 B
	2022	898.8 M
	2021	932 M
	2020	694.5 M
	2019	552.8 M

Other Fundumenentals of IDEXX Laboratories

Non Operating Income Net Other

IDEXX Laboratories Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Short Term Debt	Common Stock	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Good Will	Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.78	0.1	0.92	0.96	0.98	0.79	0.97	0.77	0.04	0.55	-0.9	0.98	0.59	0.84	0.57	0.06	0.72	0.87	-0.58	-0.44	0.76	0.77	0.63	0.68
Total Stockholder Equity	0.78		-0.51	0.93	0.66	0.74	0.23	0.73	0.7	-0.42	0.19	-0.62	0.71	0.12	0.62	-0.01	0.47	0.21	0.54	-0.73	-0.4	0.72	0.86	0.69	0.72
Net Debt	0.1	-0.51		-0.24	0.24	0.16	0.66	0.13	-0.02	0.76	0.43	-0.25	0.15	0.57	0.22	0.75	-0.56	0.59	0.31	0.33	0.11	-0.03	-0.28	-0.24	-0.3
Retained Earnings	0.92	0.93	-0.24		0.84	0.89	0.52	0.85	0.79	-0.19	0.32	-0.81	0.88	0.37	0.76	0.25	0.29	0.45	0.74	-0.72	-0.39	0.81	0.83	0.6	0.76
Accounts Payable	0.96	0.66	0.24	0.84		0.97	0.84	0.89	0.77	0.09	0.54	-0.92	0.97	0.67	0.88	0.66	0.07	0.78	0.9	-0.59	-0.46	0.69	0.67	0.52	0.62
Net Receivables	0.98	0.74	0.16	0.89	0.97		0.79	0.91	0.76	0.01	0.51	-0.92	0.97	0.65	0.88	0.62	0.16	0.74	0.9	-0.67	-0.49	0.77	0.74	0.63	0.62
Total Liab	0.79	0.23	0.66	0.52	0.84	0.79		0.79	0.51	0.47	0.67	-0.79	0.82	0.8	0.71	0.89	-0.36	0.92	0.82	-0.18	-0.29	0.47	0.36	0.3	0.35
Total Current Assets	0.97	0.73	0.13	0.85	0.89	0.91	0.79		0.71	0.17	0.6	-0.82	0.9	0.52	0.77	0.55	-0.06	0.7	0.8	-0.4	-0.33	0.7	0.76	0.65	0.63
Intangible Assets	0.77	0.7	-0.02	0.79	0.77	0.76	0.51	0.71		0.04	0.61	-0.8	0.73	0.39	0.88	0.27	0.31	0.43	0.71	-0.49	-0.23	0.7	0.66	0.39	0.37
Short Term Debt	0.04	-0.42	0.76	-0.19	0.09	0.01	0.47	0.17	0.04		0.43	-0.08	0.01	0.16	0.07	0.32	-0.73	0.23	0.06	0.59	0.61	0.06	-0.29	-0.45	-0.21
Common Stock	0.55	0.19	0.43	0.32	0.54	0.51	0.67	0.6	0.61	0.43		-0.65	0.54	0.61	0.63	0.56	-0.24	0.57	0.54	0.05	-0.2	0.22	0.2	0.2	0.0
Treasury Stock	-0.9	-0.62	-0.25	-0.81	-0.92	-0.92	-0.79	-0.82	-0.8	-0.08	-0.65		-0.91	-0.78	-0.9	-0.66	-0.15	-0.74	-0.88	0.58	0.52	-0.65	-0.61	-0.52	-0.46
Property Plant Equipment	0.98	0.71	0.15	0.88	0.97	0.97	0.82	0.9	0.73	0.01	0.54	-0.91		0.68	0.84	0.64	0.04	0.78	0.9	-0.61	-0.51	0.7	0.68	0.56	0.67
Current Deferred Revenue	0.59	0.12	0.57	0.37	0.67	0.65	0.8	0.52	0.39	0.16	0.61	-0.78	0.68		0.69	0.89	-0.14	0.87	0.79	-0.34	-0.59	0.31	0.27	0.37	0.06
Good Will	0.84	0.62	0.22	0.76	0.88	0.88	0.71	0.77	0.88	0.07	0.63	-0.9	0.84	0.69		0.58	0.19	0.71	0.93	-0.57	-0.39	0.77	0.72	0.53	0.26
Long Term Debt	0.57	-0.01	0.75	0.25	0.66	0.62	0.89	0.55	0.27	0.32	0.56	-0.66	0.64	0.89	0.58		-0.28	0.95	0.74	-0.15	-0.49	0.22	0.21	0.34	0.09
Net Tangible Assets	0.06	0.47	-0.56	0.29	0.07	0.16	-0.36	-0.06	0.31	-0.73	-0.24	-0.15	0.04	-0.14	0.19	-0.28		-0.25	0.03	-0.65	-0.43	0.11	0.28	0.36	0.16
Long Term Debt Total	0.72	0.21	0.59	0.45	0.78	0.74	0.92	0.7	0.43	0.23	0.57	-0.74	0.78	0.87	0.71	0.95	-0.25		0.88	-0.27	-0.51	0.41	0.44	0.47	0.22
Capital Surpluse	0.87	0.54	0.31	0.74	0.9	0.9	0.82	0.8	0.71	0.06	0.54	-0.88	0.9	0.79	0.93	0.74	0.03	0.88		-0.57	-0.47	0.74	0.71	0.58	0.32
Deferred Long Term Liab	-0.58	-0.73	0.33	-0.72	-0.59	-0.67	-0.18	-0.4	-0.49	0.59	0.05	0.58	-0.61	-0.34	-0.57	-0.15	-0.65	-0.27	-0.57		0.59	-0.6	-0.6	-0.55	-0.51
Short Long Term Debt	-0.44	-0.4	0.11	-0.39	-0.46	-0.49	-0.29	-0.33	-0.23	0.61	-0.2	0.52	-0.51	-0.59	-0.39	-0.49	-0.43	-0.51	-0.47	0.59		-0.04	-0.39	-0.7	-0.31
Long Term Investments	0.76	0.72	-0.03	0.81	0.69	0.77	0.47	0.7	0.7	0.06	0.22	-0.65	0.7	0.31	0.77	0.22	0.11	0.41	0.74	-0.6	-0.04		0.79	0.46	0.4
Net Invested Capital	0.77	0.86	-0.28	0.83	0.67	0.74	0.36	0.76	0.66	-0.29	0.2	-0.61	0.68	0.27	0.72	0.21	0.28	0.44	0.71	-0.6	-0.39	0.79		0.84	0.46
Net Working Capital	0.63	0.69	-0.24	0.6	0.52	0.63	0.3	0.65	0.39	-0.45	0.2	-0.52	0.56	0.37	0.53	0.34	0.36	0.47	0.58	-0.55	-0.7	0.46	0.84		0.34
Capital Stock	0.68	0.72	-0.3	0.76	0.62	0.62	0.35	0.63	0.37	-0.21	0.0	-0.46	0.67	0.06	0.26	0.09	0.16	0.22	0.32	-0.51	-0.31	0.4	0.46	0.34

Click cells to compare fundamentals

About IDEXX Laboratories Financial Statements

IDEXX Laboratories investors use historical fundamental indicators, such as IDEXX Laboratories' Operating Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in IDEXX Laboratories. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Operating Income	1.1 B	1.2 B
Non Operating Income Net Other	958.5 K	1.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for IDEXX Stock Analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

IDEXX Operating Income from 2010 to 2025

Latest IDEXX Laboratories' Operating Income Growth Pattern

IDEXX Operating Income Regression Statistics

IDEXX Operating Income History

Other Fundumenentals of IDEXX Laboratories

IDEXX Laboratories Operating Income component correlations

About IDEXX Laboratories Financial Statements

Also Currently Popular

Additional Tools for IDEXX Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY